Meliha Nalçacı

10PUBLICATIONS
77CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Molecular targetsHaematological tumoursPredictive and prognostic markersRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 30, 2026
Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients.

|Jun 27, 2025
CalR and MPL Driver Mutations and Their Role in the Diagnosis and Clinical Course of JAK2-Unmutated Chronic Myeloproliferative Neoplasm: Results from a Pilot Single-Center Study.

Tarık Onur Tiryaki, Aynur Dağlar Aday, Meliha Nalçacı

|Aug 08, 2024
Secondary Solid Cancers in Patients with Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Multicenter Study

Fehmi Hindilerden, Özge Nuran Akay, Elif Aksoy

|Aug 16, 2023
Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms

İpek Yönal-Hindilerden, Ezgi Şahin, Fehmi Hindilerden

|Sep 14, 2022
Turkey real-life data: demographic features, treatment results and effects of comorbidities in chronic myeloid leukemia.

Guray Saydam, Ali Unal, Ibrahim Celalettin Haznedaroglu

|Jun 03, 2022
Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience

Murat Özbalak, Metban Güzel Mastanzade, Özden Özlük

Pageof 2

Frequent Collaborators

4 joint publications

Aynur Dağlar-Aday

4 joint publications

İpek Yönal-Hindilerden

4 joint publications

Fehmi Hindilerden

3 joint publications

Burhan Ferhanoglu